-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83

Reuters·08/07/2026 11:04:14

Please log in to view news